MedTrace Logo

Bioimpedance Analysis for Hemodialysis

NCT06573567 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-13

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if bioimpedance-guided fluid management can help decrease hemodialysis complications. The main questions it aims to answer are:

Does bioimpedance-guided fluid management decrease major cardiovascular events? Does bioimpedance-guided fluid management decrease other hemodialysis complications?

Participants will:

Take bioimpedance analysis once per month Adjust dry weight according to the analysis as possible in active group Blind the analysis results to the doctor and the patient in the control group

Conditions

  • Hemodialysis Complication

Interventions

DEVICE

Bioimpedance

Experimental: use overhydration value obtained by bioimpedance analysis to guide fluid management; the measurements will be obtained once per month

DEVICE

Control

Placebo Comparator: the measurements will also be obtained once per month, but not revealed to the participants and the care providers

Sponsors & Collaborators

  • Cishan Hospital, Ministry of Health and Welfare

    lead OTHER

Principal Investigators

  • Han-Ming Kuo, Master · Cishan Hospital, MOHW, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2026-02-11
Completion
2026-02-11

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06573567 on ClinicalTrials.gov